Fundraising FoxBioarray Therapeutics
New Haven, US · Delaware corporation
Find your way into Bioarray Therapeutics
Sign up to see every warm intro you have to Bioarray Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioarray Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MF
Marcia FournierNamed on SEC filing
Board
HK
Henry KayBoard director
MP
Michael PremingerBoard director
PO
Patrick O'NeillBoard director
UR
Una RyanBoard director
Reported raises · per SEC filings
Form D private placements$6.7M disclosed across 2 rounds · 2015–2017
▶$5.2MraisedSep 2017 · 20 investors · Other Health CareRule 506(b)
▶$5.2MraisedSep 2017 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marcia FournierExecutive Officer, Director
- Henry KayDirector
- Zafrira AvnurDirector
- Pauline MurphyDirector
- Pamela LaytonExecutive Officer, Director
- Michal PremingerDirector
- Jim LaFranceDirector
- Offering amount
- $5.2M
- Amount sold
- $5.2M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2015 · 22 investors · Other Health CareRule 506(b)
▶$1.5MraisedMay 2015 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Henry KayDirector
- Michael PremingerDirector
- Patrick O'NeillDirector
- Una RyanDirector
- Marcia FournierExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $1.5M
- Proceeds to insiders
- $150K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Bioarray Therapeutics raised?
- Bioarray Therapeutics has disclosed $6.7M raised across 2 rounds.
- Where is Bioarray Therapeutics headquartered?
- Bioarray Therapeutics is headquartered in New Haven, US.